Stem cell therapies - K-STEMCELL

Drug Profile

Stem cell therapies - K-STEMCELL

Alternative Names: Adipose stem cell therapies - K-STEMCELL; Adult-derived stem cell therapies - K-STEMCELL; Astrostem; Autologous adipose stem cells - K-STEMCELL; Autologous Adipose Tissue derived MSCs Transplantation - K-STEMCELL; Cancerstem; Fat-derived stem cell therapies - K-STEMCELL; JointStem; Lipostem-DM; Lipostem-Femoran; Mesenchymal stem cell therapies - K-STEMCELL; RNL-JointStem; RNL-Vascostem; Vascostem

Latest Information Update: 20 Apr 2018

Price : *
* Final gross price and currency may vary according to local VAT and billing address.
* Your purchase entitles you to full access to the information contained in our drug profile at the time of purchase. A link to download a PDF version of the drug profile will be included in your email receipt. Adis is an information provider. We do not sell or distribute the pharmaceutical compounds written about in this database.

At a glance

  • Originator RNL BIO
  • Developer Asan Medical Center; K-STEMCELL; Nature cell
  • Class Antineoplastics; Stem cell therapies
  • Mechanism of Action Cell replacements
  • Orphan Drug Status

    Orphan designation is assigned by a regulatory body to encourage companies to develop drugs for rare diseases.

  • New Molecular Entity No

Highest Development Phases

  • Phase II/III Osteoarthritis
  • Phase II Alzheimer's disease
  • Phase I/II Femur head necrosis; Intervertebral disc degeneration; Spinal cord injuries; Thromboangiitis obliterans
  • Preclinical Cancer; Cerebral infarction; Diabetes mellitus; Fracture; Ischaemic heart disorders
  • No development reported Facial hemiatrophy; Liver disorders; Peripheral vascular disorders

Most Recent Events

  • 13 Apr 2018 Ministry of Health, Labor and Welfare approves use of stem cell therapy for Alzheimer’s disease in Japan under the Safety of Regenerative Medicine act
  • 10 Mar 2017 Phase-I clinical trials in Alzheimer's disease in USA (IV)
  • 10 Mar 2017 Phase-II clinical trials in Alzheimer's disease in USA (IV)
Restricted Access

Oops, it looks like you don’t have a valid subscription to this content. To gain full access to the content and functionality of the AdisInsight database try one of the following.

  • with a username/password associated to an account with a valid subscription
  • Contact your organization’s admin about adding this content to your AdisInsight subscription
  • Request a trial

If you are a subscriber to this content then contact us at so we can help.

Back to top